Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.

Study ID
NCT01067053

Study type
Interventional

Study phase
Phase 2

Study status
Unknown status

Trial Acronym

BECOX

Trial Summary

The purpose of this study is to determine whether bevacizumab, capecitabine and oxaliplatin are an effective and safe first line of treatment for elderly patients with metastatic colorectal adenocarcinoma.

More informations

Trial Starting Date

Nov 30,2009

Requirements

Gender All
Minimum age 70 Years
Maximum age N/A

Enrollement Limit